Skip to Content

DROXIA 6337 (Droxia 400 MG)

Generic Name: hydroxyurea

This pill with imprint "DROXIA 6337" is Orange, Capsule-shape and has been identified as Droxia 400 MG. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 400 MG is not a controlled substance under the Controlled Substance Act (CSA).

Images for DROXIA 6337

Droxia

Generic Name:
hydroxyurea
Imprint:
DROXIA 6337
Strength:
400 MG
Color:
Orange
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
D&C Red No. 28
D&C Red No. 33
D&C Yellow No. 10
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide